Related Experiment Video
Updated: Aug 25, 2026

Bioprospecting of Extremophilic Microorganisms to Address Environmental Pollution
Published on: December 30, 2021
Bioprospecting Indoor Bacteria Producing Bioactive Metabolites
Maria A Andersson1, Szabolcs Nagy2, Balázs Kakasi3
1Department of Civil Engineering, Aalto University, Espoo, Finland.
None:
New biomolecules are prospected for new antimicrobial, antiparasitic and cytostatic drugs. Here, we present bioassay-guided methods for prospecting indoor bacteria producing non-protein antibiotic molecules. Out of 650 bacterial colonies tested, 108 antimicrobial isolates representing 15 species and cryptic Actinobacteria, produced non-protein antibiotics affecting mammalian cells. Methanol extracts of the 108 strains tested with a battery of bioassays revealed four toxicity endpoints: (1) Cell death (CD). (2) Boar sperm motility inhibition (BSMI). (3) Inhibition of cell proliferation (ICP). (4) Mitochondrial toxicity (MT). The battery of endpoints divided the 108 strains into four toxicity profiles: Profile I: Lethal toxins (42 strains). Positive controls: Alamethicin, a channel forming ionophore and a biosurfactant surfactin. Profile II: Sublethal mitochondrial toxins (51 strains). Positive controls: The mitochondrial toxins valinomycin and antimycin A. Profile III: Sublethal cytostatic toxins (7 strains). Positive control: Chaetoglobosin A, a glucose transport inhibitor. Profile IV: Cytostatic toxins (8 strains). Positive controls: Actinomycin D, RNA syntesis inhibitor. Strains of Bacillus, Streptomyces and Paenibacillus produced amylosin, cereulide, surfactins, lichenysins, iturins, fengysin, valinomycin and fusarisidins. Strains of Peribacillus Lysinibacillus, Microbacterium, Nocardiopsis and cryptic Actnobacteria produced possible novel bioactive molecules. The indoor environments were easily accessible habitats for bacteria producing ionophores, surfactants, and mitochondrial toxins.
Related Concept Videos
Production of Antibiotics
iChip
Bioremediation
Production of Pharmaceuticals
Biosynthesis in Bacteria
Green Algae

